- Home
- SHMD vs RNAC Comparison
SHMD vs RNAC Comparison
Compare SHMD & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHMD | RNAC |
|---|---|---|
| Founded | 1864 | 2007 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 218.4M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SHMD | RNAC |
|---|---|---|
| Price | $4.51 | $7.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | ★ 1.4M | 125.5K |
| Earning Date | 05-15-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | $49.82 | N/A |
| Revenue Next Year | $36.39 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.34 | $5.60 |
| 52 Week High | $10.65 | $11.00 |
Technical Indicators
Market Signals| Indicator | SHMD | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 59.49 | 29.81 |
| Support Level | $3.80 | $5.88 |
| Resistance Level | $7.36 | $7.63 |
| Average True Range (ATR) | 0.44 | 0.40 |
| MACD | 0.16 | -0.06 |
| Stochastic Oscillator | 70.77 | 12.02 |
Price Performance
Historical ComparisonAbout SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.